I had previously looked at Grail and the Galleri test and understood then (approx 12-18 months ago) that the sensitivity for early stages is poor. Just did a quick google then and came up with the below.
I think IIQ's SubB2M is still in with a very good chance. DYOR of course.
https://www.health.com/condition/cancer/galleri-cancer-blood-test
Ann: Appendix 4E and Preliminary Financial Report, page-10
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.0¢ |
Change
-0.010(1.67%) |
Mkt cap ! $65.06M | |||
| Open | High | Low | Value | Volume |
| 60.0¢ | 60.0¢ | 59.0¢ | $17.47K | 29.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 41547 | 58.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 61.0¢ | 13799 | 4 |
View Market Depth
| Last trade - 15.51pm 26/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |